As­traZeneca pub­lish­es in­ter­im vac­cine da­ta in Lancet, re­veals 10 hos­pi­tal­iza­tions, 1 death in piv­otal con­trol arms

Af­ter read­ing out in­ter­im re­sults in mid-No­vem­ber, As­traZeneca has been hot on the heels of Pfiz­er and Mod­er­na in get­ting its ade­n­ovirus-based vac­cine past reg­u­la­tors’ …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER